787583-71-5 Usage
Uses
Used in Pharmaceutical Industry:
[1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-(4-chloro-3-fluorophenyl)-1,1-dimethylethyl]amino]-2-hydroxypropoxy]ethyl]-3-methylis used as a potential pharmaceutical agent for its possible pharmacological activity due to the presence of a substituted amine group, which may contribute to its interaction with biological targets.
Used in Organic Synthesis:
In the field of organic synthesis, this compound serves as a building block or intermediate for the synthesis of more complex organic molecules, leveraging its biphenyl carboxylic acid group and unique amine substitution for the creation of novel chemical entities.
Used in Medicinal Chemistry:
[1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-(4-chloro-3-fluorophenyl)-1,1-dimethylethyl]amino]-2-hydroxypropoxy]ethyl]-3-methylis utilized in medicinal chemistry for the development of new drugs, given its structural complexity and the potential for it to be optimized for specific therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 787583-71-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,7,5,8 and 3 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 787583-71:
(8*7)+(7*8)+(6*7)+(5*5)+(4*8)+(3*3)+(2*7)+(1*1)=235
235 % 10 = 5
So 787583-71-5 is a valid CAS Registry Number.
787583-71-5Relevant articles and documents
Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone
Shinagawa, Yuko,Inoue, Teruhiko,Katsushima, Takeo,Kiguchi, Toshihiro,Ikenogami, Taku,Ogawa, Naoki,Fukuda, Kenji,Hirata, Kazuyuki,Harada, Kazuhito,Takagi, Masaki,Nakagawa, Takashi,Kimura, Shuichi,Matsuo, Yushi,Maekawa, Mariko,Hayashi, Mikio,Soejima, Yuki,Takahashi, Mitsuru,Shindo, Masanori,Hashimoto, Hiromasa
, p. 238 - 242 (2011/04/26)
Short-acting oral calcilytics, calcium-sensing receptor (CaSR) antagonists, have been considered as alternatives for parathyroid hormone (PTH), an injectable bone anabolic drug used in the treatment of osteoporosis. Previously, we identified aminopropandi
PRODUCTION METHOD OF CARBOXYLIC ACID COMPOUND
-
Page/Page column 13, (2010/12/29)
The present invention provides the production method of carboxylic acid compound, as shown in Scheme I.
CaSR antagonist
-
Page/Page column 42, (2010/02/10)
A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: wherein each symbol is as defined in the specification. A compound having a calcium-sensing receptor antagonistic action, a pharmaceutical composition comprising the compound, particularly a calcium receptor antagonist and a therapeutic drug for osteoporosis are provided.